John S. Struck serves as Senior Vice President of Value & Access at EMD Serono, where he leads enterprise-wide strategies to ensure timely access, comprehensive coverage, and sustainable reimbursement for therapies that transform lives. His responsibilities span market access, pricing, payer engagement, and patient support programs across fertility, oncology, and neurology.

With extensive pharmaceutical expertise in Customers, Market Access, Launch Excellence, and US healthcare system dynamics, John brings a holistic perspective to delivering patient-first solutions. He is committed to creating a frictionless, optimal patient experience by removing barriers to care and championing affordability.

John’s leadership includes forging strategic partnerships with the majority of key entities that comprise the US market access landscape, while advancing value-based care and value-based pricing models to align outcomes with cost efficiency. 

Under his guidance, EMD Serono has maintained its position as a leader in fertility treatments and successfully launched Mavenclad, while preparing for future U.S. launches that will expand access to innovative therapies.

He also drives innovation in pricing frameworks—including Most-Favored-Nation (MFN) models—and policy shaping to advance sustainable healthcare systems. His work reflects EMD Serono’s mission of improving lives through science and innovation, while fostering collaboration across commercial, medical, and market access teams to deliver impact at scale.